188 related articles for article (PubMed ID: 33606748)
1. Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues.
Nürge B; Schulz AL; Kaemmerer D; Sänger J; Evert K; Schulz S; Lupp A
PLoS One; 2021; 16(2):e0246939. PubMed ID: 33606748
[TBL] [Abstract][Full Text] [Related]
2. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ.
Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM
J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
[TBL] [Abstract][Full Text] [Related]
4. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
[TBL] [Abstract][Full Text] [Related]
5. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1
Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG
Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586
[TBL] [Abstract][Full Text] [Related]
6. Expression of free fatty acid receptor 2 in normal and neoplastic tissues.
Ruhnke N; Beyer AL; Kaemmerer D; Sänger J; Schulz S; Lupp A
Exp Mol Pathol; 2024 May; 137():104902. PubMed ID: 38788249
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
8. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
Front Immunol; 2020; 11():1789. PubMed ID: 32983087
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
Ajona D; Zandueta C; Corrales L; Moreno H; Pajares MJ; Ortiz-Espinosa S; Martínez-Terroba E; Perurena N; de Miguel FJ; Jantus-Lewintre E; Camps C; Vicent S; Agorreta J; Montuenga LM; Pio R; Lecanda F
Am J Respir Crit Care Med; 2018 May; 197(9):1164-1176. PubMed ID: 29327939
[TBL] [Abstract][Full Text] [Related]
10. Allergen-Induced C5a/C5aR1 Axis Activation in Pulmonary CD11b
Antoniou K; Ender F; Vollbrandt T; Laumonnier Y; Rathmann F; Pasare C; Singh H; Köhl J
Cells; 2020 Jan; 9(2):. PubMed ID: 31991941
[TBL] [Abstract][Full Text] [Related]
11. A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages.
Moreno-Fernandez ME; Aliberti J; Groeneweg S; Köhl J; Chougnet CA
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):399-408. PubMed ID: 26537334
[TBL] [Abstract][Full Text] [Related]
12. The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension.
Weiss S; Rosendahl A; Czesla D; Meyer-Schwesinger C; Stahl RA; Ehmke H; Kurts C; Zipfel PF; Köhl J; Wenzel UO
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1356-65. PubMed ID: 27053686
[TBL] [Abstract][Full Text] [Related]
13. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
[TBL] [Abstract][Full Text] [Related]
14. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
15. Epithelial C5aR1 Signaling Enhances Uropathogenic
Song Y; Wu KY; Wu W; Duan ZY; Gao YF; Zhang LD; Chong T; Garstka MA; Zhou W; Li K
Front Immunol; 2018; 9():949. PubMed ID: 29765378
[TBL] [Abstract][Full Text] [Related]
16. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
[TBL] [Abstract][Full Text] [Related]
17. C5aR1 is a master regulator in Colorectal Tumorigenesis via Immune modulation.
Ding P; Li L; Li L; Lv X; Zhou D; Wang Q; Chen J; Yang C; Xu E; Dai W; Zhang X; Wang N; Wang Q; Zhang W; Zhang L; Zhou Y; Gu H; Lei Q; Zhou X; Hu W
Theranostics; 2020; 10(19):8619-8632. PubMed ID: 32754267
[TBL] [Abstract][Full Text] [Related]
18. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
19. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
Front Immunol; 2019; 10():1866. PubMed ID: 31447855
[TBL] [Abstract][Full Text] [Related]
20. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
Sadik CD; Miyabe Y; Sezin T; Luster AD
Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
